TG Therapeutics, Inc.
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituxima…
Biotechnology
US, New York [HQ]
TGTX/Financial Reporting
Income Statements
15 Sheets · Starting from 2023In Million USD. Margins, Growth Rates In %
| Metric | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | 6.00 | 2.00 | 233.00 | |
|
EPS
|
-111.24 | 15.68 | -0.44 | -1.38 | -0.81 | -1.64 | -1.38 | -1.60 | -1.91 | -2.30 | -2.03 | -2.48 | -2.69 | -1.51 | 0.09 | |
| Diluted in mil. | -111.24 | 15.68 | -0.44 | -1.38 | -0.81 | -1.64 | -1.38 | -1.60 | -1.91 | -2.30 | -2.03 | -2.48 | -2.69 | -1.51 | 0.09 | |
|
Profit
|
- - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | 5.00 | 2.00 | 219.00 | |
| Gross Margin | - - | - - | - - | 100.00 | 100.00 | 100.00 | 100.00 | 58.68 | 45.95 | 42.11 | -85.53 | -146.05 | 88.19 | 90.48 | 93.77 | |
| Pre Tax | -2.00 | 1.00 | - - | -25.00 | -20.00 | -55.00 | -62.00 | -78.00 | -118.00 | -173.00 | -172.00 | -279.00 | -348.00 | -198.00 | 13.00 | |
| Profit Margin | - - | - - | - - | -135,725.28 | -13,438.82 | -36,606.45 | -41,310.04 | -51,353.45 | -77,749.86 | -114,132.89 | -113,730.92 | -183,803.29 | -5,204.08 | -7,121.54 | 5.59 | |
| ETR | -36.08 | -196.13 | 4.05 | -1.28 | 12.15 | -0.11 | 0.37 | 0.92 | 0.20 | 0.53 | -3.75 | -2.33 | -2.14 | -2.77 | 2.99 | |
| Net | -2.00 | - - | - - | -18.00 | -20.00 | -55.00 | -62.00 | -78.00 | -118.00 | -173.00 | -179.00 | -285.00 | -355.00 | -203.00 | 12.00 | |
| Profit Margin | - - | - - | - - | -94,879.88 | -13,438.82 | -36,606.45 | -41,310.04 | -51,353.45 | -77,749.86 | -114,132.89 | -117,991.45 | -188,077.63 | -5,315.47 | -7,318.89 | 5.42 | |
| EBITDA | -1.00 | -5.00 | - - | -23.00 | -16.00 | -54.00 | -61.00 | -78.00 | -118.00 | -174.00 | -167.00 | -273.00 | -342.00 | -188.00 | 21.00 | |
| EBITDA Margin | - - | - - | - - | -125,170.66 | -10,977.56 | -35,995.68 | -40,671.68 | -51,823.47 | -77,904.56 | -114,678.95 | -110,252.63 | -179,639.47 | -5,119.79 | -6,755.62 | 9.01 | |
| Operating Income | -1.00 | -2.00 | - - | -26.00 | -22.00 | -55.00 | -63.00 | -78.00 | -118.00 | -174.00 | -169.00 | -273.00 | -344.00 | -192.00 | 20.00 | |
| Operating Margin | - - | - - | - - | -141,196.45 | -15,071.43 | -36,566.96 | -41,461.87 | -51,823.47 | -77,904.56 | -114,736.84 | -111,220.39 | -179,996.05 | -5,154.28 | -6,924.20 | 8.83 | |
| Interest Income | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | 5.00 | 6.00 | 5.00 | 10.00 | - - | |
| Loss | -1.00 | -2.00 | - - | -25.00 | -20.00 | -55.00 | -63.00 | -79.00 | -118.00 | -174.00 | -169.00 | -273.00 | -351.00 | -195.00 | -213.00 | |
| Cost of Revenue | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | -14.00 | |
|
Operating Expenses
|
-1.00 | -2.00 | - - | -25.00 | -20.00 | -55.00 | -63.00 | -79.00 | -118.00 | -174.00 | -169.00 | -273.00 | -350.00 | -195.00 | -198.00 | |
| R&D | - - | - - | - - | -20.00 | -12.00 | -31.00 | -43.00 | -66.00 | -96.00 | -153.00 | -148.00 | -151.00 | -198.00 | -112.00 | -76.00 | |
| G&A | -1.00 | -1.00 | -468.00 | -5.00 | -7.00 | -24.00 | -19.00 | -12.00 | -21.00 | -20.00 | -20.00 | -121.00 | -152.00 | -83.00 | -135.00 | |
| SG&A | -1.00 | -1.00 | - - | -5.00 | -7.00 | -24.00 | -19.00 | -12.00 | -21.00 | -20.00 | -20.00 | -121.00 | -152.00 | -83.00 | -122.00 | |
| S&M | - - | - - | -467.00 | - - | -1.00 | -8.00 | -4.00 | -2.00 | -5.00 | -5.00 | - - | -41.00 | -90.00 | -64.00 | -13.00 | |
| Depreciation and Amortization | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Interest Expenses | - - | -1.00 | - - | - - | - - | - - | - - | - - | - - | - - | -5.00 | -6.00 | -5.00 | -10.00 | -12.00 | |
| Other Expenses | -1.00 | -3.00 | - - | - - | - - | - - | -1.00 | - - | - - | - - | -3.00 | -5.00 | -3.00 | -5.00 | -7.00 | |
|
WA Shares Outstanding
|
- - | - - | 1.00 | 13.00 | 25.00 | 34.00 | 45.00 | 49.00 | 62.00 | 75.00 | 88.00 | 115.00 | 132.00 | 135.00 | 141.00 | |
| Diluted | - - | - - | 1.00 | 13.00 | 25.00 | 34.00 | 45.00 | 49.00 | 62.00 | 75.00 | 88.00 | 115.00 | 132.00 | 135.00 | 148.00 |